NCT00426218View on ClinicalTrials.gov

Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

March 31, 2010

Conditions

Arthritis, Juvenile Rheumatoid

Interventions

DRUG

ACZ885

Trial Locations (1)

Unknown

Novartis Investigative site, Origgio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY